Stockscreener 앱 받기
46.16
5.00%
2.20
Corcept Therapeutics Inc 주식(CORT)의 최신 뉴스
Corcept 96 Hour Deadline Alert: Kahn Swick & Foti, LLC Reminds Investors With Losses In Excess Of $100,000 of Deadline in Class Action Lawsuit Against Corcept Therapeutics IncorporatedCORT - Business Wire
Corcept Therapeutics (CORT) outlines 2026 votes on directors, auditor, executive pay and equity plan - Stock Titan
High cortisol linked to a quarter of hard-to-treat hypertension cases - Cushing's Disease News
Bronstein, Gewirtz & Grossman LLC Urges Corcept Therapeutics Incorporated Investors to Act: Class Action Filed Alleging Investor Harm - GlobeNewswire Inc.
CORT Shareholder Alert: April 21, 2026 Lead Plaintiff Deadline in Corcept Therapeutics ... - Bluefield Daily Telegraph
CORT SHAREHOLDER ALERT: Hagens Berman Alerts Corcept Therapeutics (CORT) Investors to Securities Class Action Following FDA Rejection and Federal Court Patent Loss - Barchart.com
Corcept Deadline: CORT Investors with Losses in Excess of $100K Have Opportunity to Lead Corcept Therapeutics Incorporated Securities Fraud Lawsuit - ChartMill
Platinum-Resistant Ovarian Cancer Market Outlook 2034: Rising Incidence and Robust Pipeline Drive Future Opportunities, analyses DelveInsight - Barchart.com
Deadline Soon: Corcept Therapeutics Incorporated (CORT) Shareholders Who Lost Money Urged To Contact The Law Offices of Frank R. Cruz About Securities Fraud Lawsuit - ChartMill
CORT INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Reminds Stockholders of Corcept Therapeutics Incorporated to Contact the Firm Today! - ACCESS Newswire
Corcept Therapeutics Shareholder Alert: ClaimsFiler Reminds - GlobeNewswire
INVESTOR NOTICE: Corcept Therapeutics (CORT) Investors with Substantial Losses Have Opportunity to Lead the Investor Class ActionHagens Berman - Sahm
CORT FINAL DEADLINE: ROSEN, A HIGHLY RECOGNIZED LAW FIRM, Encourages Corcept Therapeutics ... - Caledonian Record
CORT FINAL DEADLINE: ROSEN, A HIGHLY RECOGNIZED LAW FIRM, - GlobeNewswire
Corcept Therapeutics (CORT) climbs 19.7% as Lifyorli gets FDA OK - MSN
Deadline Alert: Corcept Therapeutics Incorporated (CORT) - GlobeNewswire
CORT INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Reminds Shareholders of Corcept Therapeutics Incorporated to Contact the Firm Today! - ACCESS Newswire
CORT INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Reminds Investors of Corcept Therapeutics Incorporated to Contact the Firm Today! - ACCESS Newswire
Corcept Therapeutics Incorporated (CORT) Shareholders Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit - PR Newswire
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Corcept Therapeutics Incorporated of Class Action Lawsuit and Upcoming Deadlines – CORT - ChartMill
CORT 1-WEEK DEADLINE ALERT: Hagens Berman Alerts Corcept - GlobeNewswire
Portnoy Law Firm Announces Class Action on Behalf of Corcept Therapeutics Incorporated Investors - GlobeNewswire
Corcept Therapeutics Incorporated Securities Fraud Class Action Result of FDA Approval Issues and 50% Stock DeclineInvestors may Contact Lewis Kahn, Esq, at Kahn Swick & Foti, LLC - ACCESS Newswire
Lead Plaintiff Deadlines in Shareholder Class Action - GlobeNewswire
Pomerantz LLP Shares Class Action Details With Shareholders in Corcept Therapeutics Incorporated – CORT - ACCESS Newswire
CORT Shareholder Alert: Corcept Therapeutics Incorporated Securi - GuruFocus
CORT Stockholders Have Opportunity to Lead Corcept Therapeutics Incorporated Class Action Lawsuit – Contact Bronstein, Gewirtz and Grossman, LLC Today! - ACCESS Newswire
CORT ALERT: Hagens Berman Alerts Corcept Therapeutics (CORT) Investors to Approaching April 21st Lead Plaintiff Deadline in Securities Fraud Class Action Over Relacorilant Failure - The Malaysian Reserve
Press releases provided by CNW - Techaeris
CORT Investors Have Opportunity to Lead Corcept Therapeutics Incorporated Securities Fraud Lawsuit - Barchart
Corcept Leaders Sued Over Drug-Approval Remarks, Stock Sales - Bloomberg Law News
Bragar Eagel & Squire, P.C. Reminds Investors that a Class - GlobeNewswire
Corcept Therapeutics Incorporated Sued for Securities Law - GlobeNewswire
CORT SHAREHOLDER ACTION ALERT: Kaplan Fox Alerts Investors of a Class Action Lawsuit Against Corcept Therapeutics, Inc. (NASDAQ: CORT) and Lead Plaintiff Deadline on April 21, 2026 - NewMediaWire
Did Lifyorli’s Landmark Ovarian Cancer Data and NCCN Nod Just Shift Corcept Therapeutics’ (CORT) Investment Narrative? - Yahoo Finance
Corcept's Lifyorli Plus Nab-Paclitaxel Improves Survival in Platinum-Resistant Ovarian Cancer - National Today
CORT Investors Have Opportunity to Lead Corcept Therapeutics Incorporated Securities Fraud Lawsuit with the Schall Law Firm - ChartMill
How The Corcept Therapeutics (CORT) Investment Story Is Shifting After Legal And Regulatory Updates - Yahoo Finance
CORT DEADLINE: ROSEN, NATIONAL TRIAL LAWYERS, Encourages Corcept Therapeutics Incorporated Investors with Losses in Excess of $100K to Secure Counsel Before Important April 21 Deadline in Securities Class ActionCORT - TMX Newsfile
Corcept’s Lifyorli shows 35% reduction in death risk for ovarian cancer - Investing.com Australia
DEADLINE ALERT: Kaplan Fox Alerts Investors to a Securities Class Action Against Corcept Therapeutics, Inc. (NASDAQ: CORT)Deadline is April 21, 2026 - NewMediaWire
FinancialContentDEADLINE ALERT: Kaplan Fox Alerts Investors to a Securities Class Action Against Corcept Therapeutics, Inc. (NASDAQ: CORT)Deadline is April 21, 2026 - FinancialContent
Corcept Therapeutics (CORT) Unveils Promising Survival Data from ROSELLA Trial - GuruFocus
Corcept Presents Complete Data from Pivotal ROSELLA Trial in SGO Late-Breaker with Simultaneous Publication in The Lancet: Lifyorli™ (Relacorilant) Plus Nab-Paclitaxel Improves Overall Survival in Patients with Platinum-Resistant Ovarian Cancer - Business Wire
1 Healthcare Stock with Promising Prospects and 2 Facing Headwinds - Yahoo Finance
Robbins LLP Reminds CORT Investors of the Pending Class - GlobeNewswire
INVESTOR DEADLINE: Corcept Therapeutics (CORT) Investors - GlobeNewswire
Bronstein, Gewirtz & Grossman LLC Urges Corcept - GlobeNewswire
CORT Shareholder Alert: Corcept Therapeutics Incorporated Securities Class Action Lawsuit ... - Bluefield Daily Telegraph
CORT Shareholder Alert: Corcept Therapeutics Incorporated - GlobeNewswire
Securities Class Action Deadline Against Corcept Therapeutics, Inc. (NASDAQ: CORT)Contact Kaplan Fox Before April 21, 2026 - FinancialContent
Analysts Offer Insights on Healthcare Companies: Autolus Therapeutics (AUTL) and Corcept Therapeutics (CORT) - The Globe and Mail
CORT Stock Price, Quote & Chart | CORCEPT THERAPEUTICS INC (NASDAQ:CORT) - ChartMill
Deadline Alert: Corcept Therapeutics Incorporated (CORT) Shareholders Who Lost Money Urged To Contact Glancy Prongay Wolke & Rotter LLP About Securities Fraud Lawsuit - GlobeNewswire
CORT DEADLINE ALERT: Kaplan Fox Reminds Investors of a Class Action Lawsuit Against Corcept Therapeutics, Inc. (NASDAQ: CORT) and Lead Plaintiff Deadline on April 21, 2026 - NewMediaWire
CORT Investors Have Opportunity to Lead Corcept - GlobeNewswire
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Corcept Therapeutics Incorporated of Class Action Lawsuit and Upcoming DeadlinesCORT - PR Newswire
Corcept Therapeutics (NASDAQ:CORT) Insider William Guyer Sells 20,000 Shares - MarketBeat
Corcept therapeutics officer Guyer sells $819k in shares By Investing.com - Investing.com UK
Corcept (NASDAQ: CORT) CDO sells 20,000 shares after option exercise - Stock Titan
2.19%
0.43%
자본화:
|
볼륨(24시간):